Revaskularizacija miokarda bez primene vantelesnog krvotoka

Contemporary treatment of coronary disease includes: drug treatment, percutaneous coronary angioplasty (PCI), with or without stent implantation and surgical myocardial revascularization. For more than 30 years, conventional coronary bypass (on-pump CABG), using cardiopulmonary bypass (CPB), represented the standard regarding myocardial revascularization, particularly in patients suffering from three vessel disease or left main coronary artery stenosis. Recent development of invasive cardiology and increased interest in coronary surgery on the beating heart (OPCAB), challenging traditional on-pump CABG procedure, as optimal strategy for the treatment of coronary artery disease. In order to improve clinical outcome, OPCAB seems to be a good choice in patients with co-morbidities critical for use of CPB. Results of OPCAB revascularization in general patient population are considerably different and require further evaluation. This review article shows the development of OPCAB and elaborates potential advantages and weaknesses of this method of revascularization, from both, theoretical and clinical point of view, compared to standard surgical myocardial revascularization.